107 related articles for article (PubMed ID: 20093412)
1. Comparison of prognostic scoring systems in primary myelofibrosis.
Morel P; Duhamel A
Blood; 2010 Jan; 115(3):745; author reply 745-6. PubMed ID: 20093412
[No Abstract] [Full Text] [Related]
2. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.
Cervantes F; Dupriez B; Pereira A; Passamonti F; Reilly JT; Morra E; Vannucchi AM; Mesa RA; Demory JL; Barosi G; Rumi E; Tefferi A
Blood; 2009 Mar; 113(13):2895-901. PubMed ID: 18988864
[TBL] [Abstract][Full Text] [Related]
3. The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis.
Gianelli U; Vener C; Bossi A; Cortinovis I; Iurlo A; Fracchiolla NS; Savi F; Moro A; Grifoni F; De Philippis C; Radice T; Bosari S; Lambertenghi Deliliers G; Cortelezzi A
Mod Pathol; 2012 Sep; 25(9):1193-202. PubMed ID: 22627739
[TBL] [Abstract][Full Text] [Related]
4. International Prognostic Scoring System-independent cytogenetic risk categorization in primary myelofibrosis.
Hussein K; Pardanani AD; Van Dyke DL; Hanson CA; Tefferi A
Blood; 2010 Jan; 115(3):496-9. PubMed ID: 19901264
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS.
Elena C; Passamonti F; Rumi E; Malcovati L; Arcaini L; Boveri E; Merli M; Pietra D; Pascutto C; Lazzarino M
Haematologica; 2011 Jan; 96(1):167-70. PubMed ID: 20884708
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance.
Hasselbalch H; Jensen BA
Eur J Haematol; 1990 Mar; 44(3):172-8. PubMed ID: 2328790
[TBL] [Abstract][Full Text] [Related]
7. Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients.
Nicolosi M; Mudireddy M; Lasho TL; Hanson CA; Ketterling RP; Gangat N; Pardanani A; Tefferi A
Leukemia; 2018 May; 32(5):1254-1258. PubMed ID: 29568091
[No Abstract] [Full Text] [Related]
8. The evolution and clinical relevance of prognostic classification systems in myelofibrosis.
Bose P; Verstovsek S
Cancer; 2016 Mar; 122(5):681-92. PubMed ID: 26717494
[TBL] [Abstract][Full Text] [Related]
9. Predictors of greater than 80% 2-year mortality in primary myelofibrosis: a Mayo Clinic study of 884 karyotypically annotated patients.
Tefferi A; Jimma T; Gangat N; Vaidya R; Begna KH; Hanson CA; Van Dyke DL; Caramazza D; Pardanani A
Blood; 2011 Oct; 118(17):4595-8. PubMed ID: 21881047
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation.
Gagelmann N; Eikema DJ; de Wreede LC; Koster L; Wolschke C; Arnold R; Kanz L; McQuaker G; Marchand T; Socié G; Bourhis JH; Mohty M; Cornelissen JJ; Chevallier P; Bernasconi P; Stelljes M; Rohrlich PS; Fanin R; Finke J; Maertens J; Blaise D; Itälä-Remes M; Labussière-Wallet H; Robin M; McLornan D; Chalandon Y; Yakoub-Agha I; Kröger N;
Biol Blood Marrow Transplant; 2019 Jun; 25(6):e204-e208. PubMed ID: 30930192
[TBL] [Abstract][Full Text] [Related]
11. GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis.
Tefferi A; Guglielmelli P; Nicolosi M; Mannelli F; Mudireddy M; Bartalucci N; Finke CM; Lasho TL; Hanson CA; Ketterling RP; Begna KH; Naseema Gangat ; Pardanani A; Vannucchi AM
Leukemia; 2018 Jul; 32(7):1631-1642. PubMed ID: 29654267
[TBL] [Abstract][Full Text] [Related]
12. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Gangat N; Caramazza D; Vaidya R; George G; Begna K; Schwager S; Van Dyke D; Hanson C; Wu W; Pardanani A; Cervantes F; Passamonti F; Tefferi A
J Clin Oncol; 2011 Feb; 29(4):392-7. PubMed ID: 21149668
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment.
Gergis U; Kuriakose E; Shore T; Mayer S; Mark T; Pearse R; Schuster M; Feldman E; Roboz G; Ritchie E; Scandura J; Wang H; Zhou XK; Silver RT; van Besien K
Clin Lymphoma Myeloma Leuk; 2016 May; 16(5):297-303. PubMed ID: 27025789
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis.
Tefferi A; Mudireddy M; Gangat N; Hanson CA; Ketterling RP; Pardanani A; Nagorney DM
Am J Hematol; 2017 Nov; 92(11):1187-1192. PubMed ID: 28782256
[TBL] [Abstract][Full Text] [Related]
15. Prognostication in MF: from CBC to cytogenetics to molecular markers.
Zhou A; Oh ST
Best Pract Res Clin Haematol; 2014 Jun; 27(2):155-64. PubMed ID: 25189726
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival.
Lucijanic M; Livun A; Tupek KM; Stoos-Veic T; Aralica G; Gecek I; Pejsa V; Kusec R
Leuk Lymphoma; 2017 Oct; 58(10):2497-2500. PubMed ID: 28278711
[No Abstract] [Full Text] [Related]
17. Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients.
Lucijanic M; Cicic D; Stoos-Veic T; Pejsa V; Rahelic D; Lucijanic T; Vasilj T; Ivic M; Sedinic M; Kusec R
Blood Cells Mol Dis; 2018 Sep; 72():14-16. PubMed ID: 29891442
[No Abstract] [Full Text] [Related]
18. The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis.
Masarova L; Verstovsek S
Clin Adv Hematol Oncol; 2019 May; 17(5):299-307. PubMed ID: 31188809
[TBL] [Abstract][Full Text] [Related]
19. The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis.
Lucijanic M; Pejsa V; Jaksic O; Mitrovic Z; Tomasovic-Loncaric C; Stoos-Veic T; Prka Z; Pirsic M; Haris V; Vasilj T; Kusec R
Acta Haematol; 2016; 136(2):98-100. PubMed ID: 27189016
[No Abstract] [Full Text] [Related]
20. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis.
Passamonti F; Giorgino T; Mora B; Guglielmelli P; Rumi E; Maffioli M; Rambaldi A; Caramella M; Komrokji R; Gotlib J; Kiladjian JJ; Cervantes F; Devos T; Palandri F; De Stefano V; Ruggeri M; Silver RT; Benevolo G; Albano F; Caramazza D; Merli M; Pietra D; Casalone R; Rotunno G; Barbui T; Cazzola M; Vannucchi AM
Leukemia; 2017 Dec; 31(12):2726-2731. PubMed ID: 28561069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
